<< CCPHA research reveals the serious health risks of drinking soda | Quidel's QuickVue Influenza A+B test receives special 510(k) clearance for H1N1 reactivity update >>

Enzo expands its capability to perform simultaneous live-cell imaging of nuclear components

Published on September 17, 2009 at 8:56 AM · No Comments

Enzo Life Sciences, a division of Enzo Biochem, Inc. (NYSE:ENZ), has added a novel new system to its CELLestial™ line of live cell analysis products, providing expanded capability to simultaneously image both the nucleus and the nucleolus in living cells, the Company announced today. Called the Total Nuclear-ID™ Green/Red Nucleolar/Nuclear Detection Kit, the new addition has been specifically optimized for demanding live cell microscopy applications.

The new system was featured in a recent issue of the publication “Microscopy Today,” in an article entitled “Red/Green Dual Fluorescence Detection of Both the Nucleus and Nucleolus in Living Cells.” In addition, Wayne Patton, Ph.D., Chief Scientific Officer for Enzo Life Sciences, presented a poster at the prestigious Microscopy and Microanalysis 2009 conference, held recently in Richmond, VA, on the utility of the kit for various drug discovery and basic cell biology applications.

"This complete system adds significant capabilities to our growing portfolio of live cell fluorescent probes to address unmet investigator needs,” said Dr. Patton. “The CELLestial™ product line encompasses a range of products optimized for various instrument platforms, including microscopes, microplate readers, flow cytometers and laser-scanning cytometers. Its introduction underscores our continuing commitment to introducing novel assay technologies that address rapidly expanding research fields and core applications in the Life Sciences."

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading